New drug duo tested to stop throat cancer return
Disease control
Not yet recruiting
This study tests whether a new drug, Becotatug vedotin, works better than the standard drug capecitabine to prevent cancer from coming back in people with advanced nasopharyngeal carcinoma. About 218 adults who have already completed initial chemo-radiation will be randomly assig…
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated May 26, 2026 11:48 UTC